Afya Limited (NASDAQ:AFYA) Receives $18.00 Average Target Price from Analysts

Posted by Brian Himes on Sep 7th, 2026

Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) have been assigned an average recommendation of “Reduce” from the six ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $18.00.

A number of brokerages recently weighed in on AFYA. JPMorgan Chase & Co. dropped their price objective on Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Zacks Research downgraded shares of Afya from a “hold” rating to a “strong sell” rating in a report on Friday, August 21st. Wall Street Zen raised shares of Afya from a “hold” rating to a “buy” rating in a research report on Saturday. Bank of America restated a “neutral” rating on shares of Afya in a report on Thursday, June 11th. Finally, Weiss Ratings downgraded shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, July 31st.

View Our Latest Research Report on Afya

Afya Stock Performance

Shares of AFYA stock opened at $14.68 on Monday. The firm has a market cap of $1.38 billion, a price-to-earnings ratio of 8.95, a PEG ratio of 1.55 and a beta of 0.35. Afya has a 52-week low of $13.00 and a 52-week high of $16.50. The company has a quick ratio of 2.20, a current ratio of 2.20 and a debt-to-equity ratio of 0.39. The company’s 50 day moving average is $14.26 and its 200 day moving average is $14.34.

Afya (NASDAQ:AFYA – Get Free Report) last posted its earnings results on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. Afya had a return on equity of 17.58% and a net margin of 20.55%.The company had revenue of $187.80 million during the quarter, compared to analyst estimates of $189.62 million. On average, sell-side analysts anticipate that Afya will post 1.84 EPS for the current fiscal year.

Insider Activity at Afya

In other news, VP Lélio de Souza, Jr. sold 36,204 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $15.00, for a total transaction of $543,060.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Gomiero Mirella Basolli sold 10,000 shares of the firm’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $14.80, for a total value of $148,000.00. Following the completion of the sale, the vice president directly owned 34,530 shares of the company’s stock, valued at $511,044. The trade was a 22.46% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 87,745 shares of company stock valued at $1,314,175.

Institutional Investors Weigh In On Afya

Institutional investors have recently added to or reduced their stakes in the business. Swedbank AB increased its holdings in shares of Afya by 170.3% during the fourth quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after acquiring an additional 119,200 shares in the last quarter. State Street Corp boosted its stake in Afya by 25.8% in the 4th quarter. State Street Corp now owns 126,914 shares of the company’s stock worth $1,955,000 after purchasing an additional 26,005 shares in the last quarter. Bank of America Corp DE boosted its stake in Afya by 11.9% in the 2nd quarter. Bank of America Corp DE now owns 86,201 shares of the company’s stock worth $1,540,000 after purchasing an additional 9,192 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in Afya by 5.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock worth $1,217,000 after purchasing an additional 3,626 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in Afya by 16.6% during the 4th quarter. Geode Capital Management LLC now owns 60,378 shares of the company’s stock valued at $930,000 after purchasing an additional 8,610 shares in the last quarter. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Company Profile

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.